Evaluation of QDOT MICRO™ Catheter for Pulmonary Vein Isolation in Subjects With Paroxysmal Atrial Fibrillation
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 283 participants.
Also called NCT03775512
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 283 participants
- Sponsor
- Registry
-
NCT03775512
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT03775512. Non-randomized; no masking; primary purpose treatment. Start 2019-01-30 (actual); primary completion 2022-02-17 (actual). Results posted on 2023-03-16.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of QDOT MICRO™ Catheter for Pulmonary Vein Isolation in Subjects With Paroxysmal Atrial Fibrillation
- Acronym
- Q-FFICIENCY
- Condition
- Paroxysmal Atrial Fibrillation
- Intervention (Device)
- RF Ablation with QDOT Micro
- Lead sponsor
- Biosense Webster, Inc.
Record details
- Record id
cardio:ct-nct03775512- Content hash
3737184662e213058fe06f679e628f9ac45dd58946d71f0db9e3e80311d399cb